Levoseboreong (Levocetirizine Hydrochloride)

Adult dose

Adults: Administer orally 1 tablet (5 mg levocetirizine hydrochloride), once daily, without regard to meals. Adjust dosage according to age and symptoms. For patients with renal impairment, dosage should be adjusted based on renal function (creatinine clearance (CLCR)). Mild (50 ≤ CLCR < 80): 1 tablet, once daily. Moderate (30 ≤ CLCR < 50): 1 tablet, once every two days. Severe (10 ≤ CLCR < 30): 1 tablet, once every three days.

Child dose

Children over 6 years: Administer orally 1 tablet (5 mg levocetirizine hydrochloride), once daily, without regard to meals.

This medication should not be used by individuals with allergies to specific components or a history of hypersensitivity. It should not be administered to patients with severely impaired renal function or those undergoing hemodialysis. It is safer for women who are pregnant or may become pregnant, as well as those who are breastfeeding, to avoid taking this medication. It must not be used in infants under 1 year of age, and for children under 6 years, it should only be administered in liquid form rather than as tablets. Patients with lactose intolerance or specific genetic lactose metabolic disorders should not use this medication due to the inclusion of lactose. Careful administration is required for patients with impaired renal or hepatic function, as well as elderly patients due to the potential for increased blood concentration of the drug. Side effects such as drowsiness, headache, dizziness, dyspepsia, and heart rhythm abnormalities may occur, and severe symptoms should prompt consultation with a doctor. Drowsiness or fatigue may occur after taking this medication, so care should be taken when performing tasks that require concentration, such as driving or operating machinery. Concurrent use with alcohol or central nervous system depressants may worsen drowsiness or loss of concentration, so it is advisable not to take them together. Patients with urinary excretion disorders or relevant diseases should be extra cautious when using this medication. This drug may affect the results of allergy tests, so it is recommended to stop taking it 3 to 5 days before the scheduled test. Symptoms of overdose may include drowsiness, anxiety, and restlessness, and there is no specific antidote, so treatment should be provided according to the symptoms. Because it is difficult to remove this medication through hemodialysis, rapid medical intervention is needed in cases of overdose.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing → severe allergic reaction. Hypertension, rash, angioedema → severe allergic reaction. Severe rash with high fever, blisters, skin peeling, oral/ocular mucosal pain → severe skin adverse reaction. Difficulty breathing, bronchospasm → respiratory problems. Yellowing of the skin or eyes (jaundice), elevated AST, ALT, Al-P, total bilirubin → hepatic abnormalities (jaundice)

Mild side effects

• Drowsiness
• lethargy
• headache
• numbness
• drowsiness
• fatigue
• dizziness
• heaviness in the head
• excitement
• thirst

This medication is sensitive to light, so it should be stored in a sealed container that blocks light. Additionally, it is important to keep it at a temperature between 1 and 30 degrees Celsius to maintain the effectiveness of the drug.

Appearance

White or pale yellow oval film-coated tablets

Package unit

30 tablets, 300 tablets